My Treatment Approach: Optimizing Care for Patients with Polycythemia Vera

Experts unpack evolving PV risk signals, from leukocytosis to symptom burden, and when to escalate beyond aspirin, phlebotomy, and hydroxyurea.

Explore how polycythemia vera symptoms like fatigue and aquagenic pruritus signal disease activity, guiding better monitoring and treatment beyond blood counts.

Polycythemia vera symptoms like fatigue and aquagenic itching signal active disease; experts urge objective tracking and tailored therapy beyond phlebotomy.

Learn how clinicians choose ruxolitinib vs interferon in polycythemia vera, balancing clot risk, symptom control, and safety monitoring.

Learn how clinicians personalize polycythemia vera therapy, weighing ruxolitinib vs interferon benefits, side effects, monitoring, and infection risk reduction.